[
    [
        {
            "time": "",
            "original_text": "福布斯中国富豪榜，马云又登顶首富！这些行业造富能力强",
            "features": {
                "keywords": [
                    "福布斯",
                    "中国",
                    "富豪榜",
                    "马云",
                    "首富",
                    "造富能力"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "科技",
                    "互联网"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "福布斯中国富豪榜，马云又登顶首富！这些行业造富能力强",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 4,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "冠脉支架集采落地，医疗耗材利空压制释放【东吴医药朱国广团队|1106周报】",
            "features": {
                "keywords": [
                    "冠脉支架",
                    "集采",
                    "医疗耗材",
                    "利空",
                    "东吴医药"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "冠脉支架集采落地，医疗耗材利空压制释放【东吴医药朱国广团队|1106周报】",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "【中航证券医药】行业周报 | 高值耗材集采落地，降价幅度超出预期",
            "features": {
                "keywords": [
                    "高值耗材",
                    "集采",
                    "降价",
                    "中航证券",
                    "医药"
                ],
                "sentiment_score": -0.8,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "医疗器械"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "【中航证券医药】行业周报 | 高值耗材集采落地，降价幅度超出预期",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "皓元医药科创板IPO 布局高难度原料药领域彰显“硬科技”",
            "features": {
                "keywords": [
                    "皓元医药",
                    "科创板",
                    "IPO",
                    "高难度原料药",
                    "硬科技"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "皓元医药科创板IPO 布局高难度原料药领域彰显“硬科技”",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "频频失手 4300亿高瓴资本投资神话能否继续？",
            "features": {
                "keywords": [
                    "高瓴资本",
                    "投资",
                    "神话",
                    "失手"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融",
                    "投资"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "频频失手 4300亿高瓴资本投资神话能否继续？",
                "Correlation": 6,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "【浙商医药|周报】估值持续回落，重点推荐有望进入业绩加速期的CDMO",
            "features": {
                "keywords": [
                    "浙商医药",
                    "估值",
                    "回落",
                    "CDMO",
                    "业绩加速"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "CDMO"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【浙商医药|周报】估值持续回落，重点推荐有望进入业绩加速期的CDMO",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        }
    ]
]